Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

65959 Press Releases
DateTitleCompany
08 May 12 Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck Cancer Advaxis Inc.,
Published by
Business Wire
08 May 12 SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE SANUWAVE Health Inc.,
Published by
Business Wire
08 May 12 Concerns over Drug Resistance in Gram-Negative Infections Has Led to the Uptake of Drugs Typically Used for Later Lines of Therapy, Including Meropenem, Merck’s Primaxin and Invanz, Janssen’s Doribax, Pfizer’s Tygacil and Colistin BioTrends Research Group LLC,
Published by
Business Wire
08 May 12 Formulation and Delivery Partnerships Draw Pharma and Life Science Firms into New Markets Lux Research Inc.,
Published by
Business Wire
08 May 12 POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries POZEN Inc.,
Published by
Business Wire
08 May 12 Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA Rexahn Pharmaceuticals Inc.,
Published by
Business Wire
08 May 12 Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease Eleven Biotherapeutics,
Published by
Business Wire
08 May 12 Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing Eleven Biotherapeutics Inc.,
Published by
Business Wire
08 May 12 Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor Blueprint Medicines,
Published by
Business Wire
08 May 12 Research and Markets: Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Research and Markets,
Published by
Business Wire
08 May 12 Apple's iPad Touch Technology to Be Used to Save 50,000 Lives ERELEASES,
Published by
PR Newswire
08 May 12 Span-America Announces Second Quarter Conference Call On the Internet CORPORATE COMMUNICATIONS/TENN.,
Published by
PR Newswire
08 May 12 ALLERGAN LAUNCHES TRIPLE ACTION OPTIVE PLUS® EYEDROPS FOR THE TREATMENT OF DRY EYES Allergan, Inc.
08 May 12 Akorn Reports Record First Quarter 2012 Financial Results Akorn Inc.,
Published by
Business Wire
08 May 12 Origin Agritech Limited Reports Unaudited Second Quarter Financial Results For Three Months Ended March 31, 2012 Origin Agritech Limited,
Published by
Business Wire
08 May 12 GTx Provides Corporate Update and Reports First Quarter 2012 Financial Results GTx Inc.,
Published by
Business Wire
08 May 12 GTx Announces Removal of Full Clinical Hold By FDA for Capesaris® In Advanced Prostate Cancer GTx Inc.,
Published by
Business Wire
08 May 12 University of Washington, University of Texas Medical Branch and Kineta, Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development Kineta Inc.,
Published by
Business Wire
08 May 12 InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on KGO-TV in San Francisco InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
08 May 12 Prosonix to Present at Respiratory Drug Delivery 2012 and American Thoracic Society 2012 International Conference Prosonix
08 May 12 ICON Releases New Web-based Good Clinical Practice Training Module ICON plc
08 May 12 Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related cytomegalovirus infections and herpes Clinigen,
Published by
Business Wire
08 May 12 Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury Abbott
08 May 12 First stone in UCB’s new Swiss biotechnology production unit to be set UCB
08 May 12 James Shannon named GlaxoSmithKline Chief Medical Officer GlaxoSmithKline
08 May 12 ChinaBio® Partnering Forum 2012 In Suzhou Brings Big Pharma Companies to China EBD Group,
Published by
Business Wire
08 May 12 iCAD Reports First Quarter Financial Results iCAD Inc.,
Published by
Business Wire
08 May 12 Dendreon Reports Net PROVENGE Product Revenues of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth Dendreon Corporation,
Published by
Business Wire
08 May 12 PerkinElmer Announces Agreement with Macrogen, Inc. to Provide Next Generation Sequencing Solutions PerkinElmer Inc.,
Published by
Business Wire
08 May 12 Minnesota Connected to Abbott Labs’ Payment of $1.5 Billion to the Government in Fraud Case Halunen & Associates,
Published by
Business Wire
Advertising